A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/Akt/mTOR signaling pathway

L Zhao, C Li, F Liu, Y Zhao, J Liu, Y Hua… - OncoTargets and …, 2017 - Taylor & Francis
… /mTOR signaling pathway, we examined the levels of PTEN, PI3K, Akt, and mTOR mRNA
expression in pancreatic cancer tissue and spontaneous liver metastases after treatment with …

Inhibition of Invasion in Pancreatic Cancer Cells by Conjugate of EPA with β3,3-Pip-OH via PI3K/Akt/NF-kB Pathway

H Amin, NA Wani, S Farooq, D Nayak… - ACS Medicinal …, 2015 - ACS Publications
… BC06 on phosphorylation of Akt and expression of PI3K and NF-… Akt (S473) and also
decreased PI3K (P85α), PI3K (P110α), and NF-KB in a dose-dependent manner (Figure 4B). As Akt

[PDF][PDF] A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway

B Li, J Yang, Z Lu, B Liu, F Liu - J BUON, 2019 - jbuon.com
… -inositol 3-kinase (PI3K)/serine-threonine kinase (AKT) signal transduction that can be …
the antitumor effect of mTOR in human pancreatic cancer SW1990 cells and to elucidate the …

[HTML][HTML] Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways

Y Hu, J Jing, Y Shi, P Zhang, D Dong… - Translational Cancer …, 2021 - ncbi.nlm.nih.gov
AKT and ERK1/2 results in tumor inhibition. Other studies similarly reported that inhibition
of the AKT/mTOR pathway promotes apoptosis and autophagy of pancreatic cancer cells (19), …

Phospho-Akt overexpression is prognostic and can be used to tailor the synergistic interaction of Akt inhibitors with gemcitabine in pancreatic cancer

D Massihnia, A Avan, N Funel, M Maftouh… - Journal of Hematology & …, 2017 - Springer
… Our results demonstrate that perifosine is the targeted anti-PI3K/Akt antitumor agent
demonstrating the most potent growth inhibitory effects in a panel of human PDAC cells …

RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer

K Leake, J Singhal, LD Nagaprashantha, S Awasthi… - PloS one, 2012 - journals.plos.org
… Effect of RLIP76 antisense on PI3K and Akt signaling in pancreatic cancer cells: RLIP76
antisense caused inhibition of PI3K/Akt pathway in BxPC-3 and Panc-1 cells. Cells were treated …

[HTML][HTML] MiR-139-5p/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K/Akt signaling pathway

JH Zhu, RA De Mello, QL Yan, JW Wang… - … et Biophysica Acta (BBA …, 2020 - Elsevier
… MiR-139-5p could regulate and affect the protein expression of P13K and Akt associated …
suppress PANC tumor growth and the expressions of SLC7A11, p-PI3K, p-Akt in tumor tissues. …

Kaempferol potentiates the sensitivity of pancreatic cancer cells to erlotinib via inhibition of the PI3K/AKT signaling pathway and epidermal growth factor receptor

Z Zhang, Y Guo, M Chen, F Chen, B Liu, C Shen - Inflammopharmacology, 2021 - Springer
… to possess potent anti-tumor and anti-inflammatory properties, … likely be related to the
PI3K/AKT signaling pathway and EGFR TKI … to ERL via inhibiting PI3K/AKT and EGFR signaling. …

SRPX2 boosts pancreatic cancer chemoresistance by activating PI3K/AKT axis

Z Gao, J Wu, X Wu, J Zheng, Y Ou - Open medicine, 2020 - degruyter.com
… affected pancreatic cancer (PC) chemoresistance by regulating PI3K/Akt/mTOR signaling. …
Therefore, this investigation was intended to disclose the interaction of SRPX2 and PI3K/Akt/…

Activation of glucagon‐like peptide‐1 receptor inhibits tumourigenicity and metastasis of human pancreatic cancer cells via PI3K/Akt pathway

H Zhao, L Wang, R Wei, D Xiu, M Tao… - Diabetes, Obesity …, 2014 - Wiley Online Library
… expression in human pancreatic cancer, we analysed normal human pancreatic tissues
and tumour tissues from patients with PDAC. First, we identified normal pancreatic and tumour …